SlideShare a Scribd company logo
1 of 22
Clinical Skills
Workshop:
Overdose Prevention and Response —
Administering Naloxone to Save Lives
POPULATION HEALTH INTEREST GROUP
SEPTEMBER 8, 2016
Conflict of Interest Disclaimer
 No financial disclosures.
 Adapt Pharma provided one trainer of its nasal spray (no medicine) for
demonstration.
 Kaleo provided Evzio autoinjectable trainers (no medicine) for
demonstration.
How bad is it?
National Overdose Deaths
Number of Deaths from Prescription Drugs
0
5,000
10,000
15,000
20,000
25,000
30,000 Total Female Male
Source: National Center for Health Statistics, CDC Wonder
National Overdose Deaths
Number of Deaths from Prescription Opioid Pain Relievers
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
20,000 Total Female Male
Source: National Center for Health Statistics, CDC Wonder
National Overdose Deaths
Number of Deaths from Heroin
0
2,000
4,000
6,000
8,000
10,000
12,000 Total Female Male
Whom are we talking about?
Break for video #1
It’s more than “use as directed”
An adverse reaction can occur if:
 Co-morbidities: lungs, liver, kidneys, etc.
 Co-pharmacy: e.g. sedative
 Genetic susceptibility
 Drinking alcohol
 User error
 Period of abstinence
 Switching opioids
 Family member may help themselves
When to write a script
 If patient is prescribed an opioid medication.
 If patient is using opioids of any kind.
 After a period of abstinence (any kind, including incarceration or drug
treatment).
 If pt. has experienced an overdose or adverse reaction.
 If pt. has witnessed an overdose or adverse reaction.
 If pt. asks for it.
 If pt. has a household member who might benefit from it.
Break for video #2
Enabling? No!
Safe? Yes!
• Been around since 1961
• Communities have been distributing
since 1996
• No compensatory behavior since it
causes withdrawal.
• No potential for abuse.
• People use it.
• Leads to treatment for substance
use disorder.
• Decrease in deaths much greater
than amount supplied, indicating
decrease in risky behavior as result
of the educational process that is
part of providing rx.
Si se puede!
 150K laypersons trained.
 26K OD reversed .
 80% of reversals were
performed by drug users
 In North Carolina, their
three-year-old program
has had 4,000 reversals.
 FDA working on making it
OTC.
 FDA changing labels on all
opiates and benzos.
Rx, OTC, Standing Order
To script or not to script
 There may not be a standing order in your state.
 Standing order may only be for certain pharmacies.
 Pharmacist may not be aware of standing order.
 Patient may not know to ask for it.
 Patient may not remember to ask for it.
 Easier to pick up all rx at once.
 Less worry about payment and billing issues.
 There is no downside to writing a script.
Your new best friend:
www.prescribetoprevent.org
One-stop shopping for patients, advocates, prescribers, pharmacists: videos,
online CME, research, legal info, billing, Rx pads, and things you never thought
you might need.
 Where do we go from here?
 Train your classmates: this is an easy brown-bag lunch session.
 Show video(s)
 Give demo
 Tell people where to get it for themselves
 Make this a national AMSA Project, educating medical students, college
students, incarcerated populations, drug treatment programs, faith
communities, etc.
Thank you!
Mary Beth Levin, MPH
Associate Professor
Department of Family Medicine
Georgetown University School of Medicine
levinmb@gmail.com
Other resources:
Harm Reduction Coalition: www.harmreduction.org
North Carolina Harm Reduction Coalition: www.nchrc.org
Chicago Recovery Alliance: www.anypoisitivechange.org

More Related Content

Viewers also liked

Xinghuo anti-glare led downlight
Xinghuo anti-glare led downlightXinghuo anti-glare led downlight
Xinghuo anti-glare led downlightNancy Xu
 
Dr kazemian
Dr kazemianDr kazemian
Dr kazemianLampesht
 
Ingredientes para elaborar tinga poblana
Ingredientes para elaborar tinga poblanaIngredientes para elaborar tinga poblana
Ingredientes para elaborar tinga poblanaTesisupaep
 
Brochure master copy
Brochure master copy Brochure master copy
Brochure master copy Julie Hickton
 
Tugas MTK3 BAB 2
Tugas MTK3 BAB 2Tugas MTK3 BAB 2
Tugas MTK3 BAB 2cinjy
 
NAFTA Relaciones Bilaterales
NAFTA Relaciones BilateralesNAFTA Relaciones Bilaterales
NAFTA Relaciones BilateralesEdgar Ortiz
 
Wellness Weekly 11.5.15
Wellness Weekly 11.5.15Wellness Weekly 11.5.15
Wellness Weekly 11.5.15Aiyana Parks
 
HANA Demystified by DataMagnum
HANA Demystified by DataMagnumHANA Demystified by DataMagnum
HANA Demystified by DataMagnumPrasad Mavuduri
 

Viewers also liked (12)

Palle Lilja CV
Palle Lilja CVPalle Lilja CV
Palle Lilja CV
 
ΦΕΚ-3860 Β/1-12-16
ΦΕΚ-3860 Β/1-12-16ΦΕΚ-3860 Β/1-12-16
ΦΕΚ-3860 Β/1-12-16
 
Apports du decret 2 12-349
Apports du decret 2 12-349Apports du decret 2 12-349
Apports du decret 2 12-349
 
Xinghuo anti-glare led downlight
Xinghuo anti-glare led downlightXinghuo anti-glare led downlight
Xinghuo anti-glare led downlight
 
Dr kazemian
Dr kazemianDr kazemian
Dr kazemian
 
Ingredientes para elaborar tinga poblana
Ingredientes para elaborar tinga poblanaIngredientes para elaborar tinga poblana
Ingredientes para elaborar tinga poblana
 
Brochure master copy
Brochure master copy Brochure master copy
Brochure master copy
 
Tugas MTK3 BAB 2
Tugas MTK3 BAB 2Tugas MTK3 BAB 2
Tugas MTK3 BAB 2
 
NAFTA Relaciones Bilaterales
NAFTA Relaciones BilateralesNAFTA Relaciones Bilaterales
NAFTA Relaciones Bilaterales
 
Wellness Weekly 11.5.15
Wellness Weekly 11.5.15Wellness Weekly 11.5.15
Wellness Weekly 11.5.15
 
Bravo Services
Bravo ServicesBravo Services
Bravo Services
 
HANA Demystified by DataMagnum
HANA Demystified by DataMagnumHANA Demystified by DataMagnum
HANA Demystified by DataMagnum
 

Similar to PHIGClinical Skills Workshop

Pharmanex Antioxidant Scanner
Pharmanex Antioxidant ScannerPharmanex Antioxidant Scanner
Pharmanex Antioxidant ScannerBill Muth
 
Health pointfw 081010
Health pointfw 081010Health pointfw 081010
Health pointfw 081010Leongum
 
Medication Error a pharmacist perspective 2-23-01
Medication Error a  pharmacist perspective 2-23-01Medication Error a  pharmacist perspective 2-23-01
Medication Error a pharmacist perspective 2-23-01Charles Sharkey
 
Med notes pocket drug guid
Med notes pocket drug guidMed notes pocket drug guid
Med notes pocket drug guidSadegh Dehghan
 
Pdmp 2 small kim_lev_zarate
Pdmp 2 small kim_lev_zaratePdmp 2 small kim_lev_zarate
Pdmp 2 small kim_lev_zarateOPUNITE
 
Infection Control Nurses: Rx For Sanity: Triage, Love and Laughter!
Infection Control Nurses: Rx For Sanity: Triage, Love and Laughter!Infection Control Nurses: Rx For Sanity: Triage, Love and Laughter!
Infection Control Nurses: Rx For Sanity: Triage, Love and Laughter!Patricia Raymond
 
Dementia care w o drugs - south sf 10-27-11
Dementia care w o drugs - south sf 10-27-11Dementia care w o drugs - south sf 10-27-11
Dementia care w o drugs - south sf 10-27-11ossmc
 
Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]lawsuitlegal
 
Complimentry and aternative medicine continued
Complimentry and aternative medicine continuedComplimentry and aternative medicine continued
Complimentry and aternative medicine continuedPositive Life
 
5.3. Methods of Disposal (Batz)
5.3. Methods of Disposal (Batz)5.3. Methods of Disposal (Batz)
5.3. Methods of Disposal (Batz)Teleosis Institute
 
Mental Health Medication Use in Washington
Mental Health Medication Use in WashingtonMental Health Medication Use in Washington
Mental Health Medication Use in WashingtonMHTP Webmastere
 
Presentation may2006masterspectrum
Presentation may2006masterspectrumPresentation may2006masterspectrum
Presentation may2006masterspectrumtaxed
 
Answering Clinical Questions at the Point of Care Answering Clinical Questi...
Answering Clinical Questions at the Point of Care 	 Answering Clinical Questi...Answering Clinical Questions at the Point of Care 	 Answering Clinical Questi...
Answering Clinical Questions at the Point of Care Answering Clinical Questi...MedicineAndHealth14
 
Biophotonic Scanner/Lifepak Nano
Biophotonic Scanner/Lifepak NanoBiophotonic Scanner/Lifepak Nano
Biophotonic Scanner/Lifepak NanoDzynr44
 
Heart condition, the short end of the stick
Heart condition, the short end of the stick Heart condition, the short end of the stick
Heart condition, the short end of the stick facedoctor
 
A Survey report on otc products and its market status
A Survey report on otc products and its market statusA Survey report on otc products and its market status
A Survey report on otc products and its market statusDeep Shah
 
May 3, 2017 OARO (On another format to see across the wall)
May 3, 2017 OARO (On another format to see across the wall)May 3, 2017 OARO (On another format to see across the wall)
May 3, 2017 OARO (On another format to see across the wall)Obaid Ali / Roohi B. Obaid
 

Similar to PHIGClinical Skills Workshop (20)

Pharmanex Antioxidant Scanner
Pharmanex Antioxidant ScannerPharmanex Antioxidant Scanner
Pharmanex Antioxidant Scanner
 
Health pointfw 081010
Health pointfw 081010Health pointfw 081010
Health pointfw 081010
 
Medication Error a pharmacist perspective 2-23-01
Medication Error a  pharmacist perspective 2-23-01Medication Error a  pharmacist perspective 2-23-01
Medication Error a pharmacist perspective 2-23-01
 
Med notes pocket drug guid
Med notes pocket drug guidMed notes pocket drug guid
Med notes pocket drug guid
 
Pdmp 2 small kim_lev_zarate
Pdmp 2 small kim_lev_zaratePdmp 2 small kim_lev_zarate
Pdmp 2 small kim_lev_zarate
 
Infection R F S092011
Infection R F S092011Infection R F S092011
Infection R F S092011
 
Infection Control Nurses: Rx For Sanity: Triage, Love and Laughter!
Infection Control Nurses: Rx For Sanity: Triage, Love and Laughter!Infection Control Nurses: Rx For Sanity: Triage, Love and Laughter!
Infection Control Nurses: Rx For Sanity: Triage, Love and Laughter!
 
Dementia care w o drugs - south sf 10-27-11
Dementia care w o drugs - south sf 10-27-11Dementia care w o drugs - south sf 10-27-11
Dementia care w o drugs - south sf 10-27-11
 
Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]Qui Tam: Off Label Drug Marketing [Data Snapshot]
Qui Tam: Off Label Drug Marketing [Data Snapshot]
 
Complimentry and aternative medicine continued
Complimentry and aternative medicine continuedComplimentry and aternative medicine continued
Complimentry and aternative medicine continued
 
804185 slide
804185 slide804185 slide
804185 slide
 
5.3. Methods of Disposal (Batz)
5.3. Methods of Disposal (Batz)5.3. Methods of Disposal (Batz)
5.3. Methods of Disposal (Batz)
 
Mental Health Medication Use in Washington
Mental Health Medication Use in WashingtonMental Health Medication Use in Washington
Mental Health Medication Use in Washington
 
Presentation may2006masterspectrum
Presentation may2006masterspectrumPresentation may2006masterspectrum
Presentation may2006masterspectrum
 
Answering Clinical Questions at the Point of Care Answering Clinical Questi...
Answering Clinical Questions at the Point of Care 	 Answering Clinical Questi...Answering Clinical Questions at the Point of Care 	 Answering Clinical Questi...
Answering Clinical Questions at the Point of Care Answering Clinical Questi...
 
SBIRT HANDOUTS
SBIRT HANDOUTSSBIRT HANDOUTS
SBIRT HANDOUTS
 
Biophotonic Scanner/Lifepak Nano
Biophotonic Scanner/Lifepak NanoBiophotonic Scanner/Lifepak Nano
Biophotonic Scanner/Lifepak Nano
 
Heart condition, the short end of the stick
Heart condition, the short end of the stick Heart condition, the short end of the stick
Heart condition, the short end of the stick
 
A Survey report on otc products and its market status
A Survey report on otc products and its market statusA Survey report on otc products and its market status
A Survey report on otc products and its market status
 
May 3, 2017 OARO (On another format to see across the wall)
May 3, 2017 OARO (On another format to see across the wall)May 3, 2017 OARO (On another format to see across the wall)
May 3, 2017 OARO (On another format to see across the wall)
 

More from Mary Beth Levin

HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)Mary Beth Levin
 
HIV prevention conference
HIV prevention conferenceHIV prevention conference
HIV prevention conferenceMary Beth Levin
 
9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBL9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBLMary Beth Levin
 
Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Mary Beth Levin
 
2 5 16 Syringe Exchange Webinar
2 5 16 Syringe Exchange Webinar2 5 16 Syringe Exchange Webinar
2 5 16 Syringe Exchange WebinarMary Beth Levin
 
APHA federal funding for SSPs
APHA federal funding for SSPsAPHA federal funding for SSPs
APHA federal funding for SSPsMary Beth Levin
 
Needle Exchange Factsheet with references
Needle Exchange Factsheet with referencesNeedle Exchange Factsheet with references
Needle Exchange Factsheet with referencesMary Beth Levin
 
060811JointstatementHIV_final_
060811JointstatementHIV_final_060811JointstatementHIV_final_
060811JointstatementHIV_final_Mary Beth Levin
 
ltr to amodei 11.20.14 re ssps
ltr to amodei 11.20.14 re sspsltr to amodei 11.20.14 re ssps
ltr to amodei 11.20.14 re sspsMary Beth Levin
 
Prevention_Works!2007-08[1]
Prevention_Works!2007-08[1]Prevention_Works!2007-08[1]
Prevention_Works!2007-08[1]Mary Beth Levin
 
PreventionWorks2009-10[1]
PreventionWorks2009-10[1]PreventionWorks2009-10[1]
PreventionWorks2009-10[1]Mary Beth Levin
 
PresentationForUpload[1]
PresentationForUpload[1]PresentationForUpload[1]
PresentationForUpload[1]Mary Beth Levin
 

More from Mary Beth Levin (20)

aan
aanaan
aan
 
HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)HEWA_Syringe_Services_Programs_10232013(2)
HEWA_Syringe_Services_Programs_10232013(2)
 
HIV prevention conference
HIV prevention conferenceHIV prevention conference
HIV prevention conference
 
hesp
hesphesp
hesp
 
9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBL9-20-2016OklahomaCityPresentationMBL
9-20-2016OklahomaCityPresentationMBL
 
Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]Meghaan Walsh HJS Poster[1]
Meghaan Walsh HJS Poster[1]
 
2 5 16 Syringe Exchange Webinar
2 5 16 Syringe Exchange Webinar2 5 16 Syringe Exchange Webinar
2 5 16 Syringe Exchange Webinar
 
APHA federal funding for SSPs
APHA federal funding for SSPsAPHA federal funding for SSPs
APHA federal funding for SSPs
 
Pingree letter 12-3-15
Pingree letter 12-3-15Pingree letter 12-3-15
Pingree letter 12-3-15
 
HJS_HIVSurveyProject
HJS_HIVSurveyProjectHJS_HIVSurveyProject
HJS_HIVSurveyProject
 
Needle Exchange Factsheet with references
Needle Exchange Factsheet with referencesNeedle Exchange Factsheet with references
Needle Exchange Factsheet with references
 
060811JointstatementHIV_final_
060811JointstatementHIV_final_060811JointstatementHIV_final_
060811JointstatementHIV_final_
 
ltr to amodei 11.20.14 re ssps
ltr to amodei 11.20.14 re sspsltr to amodei 11.20.14 re ssps
ltr to amodei 11.20.14 re ssps
 
Nevada December 17
Nevada December 17Nevada December 17
Nevada December 17
 
pwposter2006-7
pwposter2006-7pwposter2006-7
pwposter2006-7
 
Prevention_Works!2007-08[1]
Prevention_Works!2007-08[1]Prevention_Works!2007-08[1]
Prevention_Works!2007-08[1]
 
PreventionWorks![2008]
PreventionWorks![2008]PreventionWorks![2008]
PreventionWorks![2008]
 
PreventionWorks2009-10[1]
PreventionWorks2009-10[1]PreventionWorks2009-10[1]
PreventionWorks2009-10[1]
 
PresentationForUpload[1]
PresentationForUpload[1]PresentationForUpload[1]
PresentationForUpload[1]
 
appletreeposter2006
appletreeposter2006appletreeposter2006
appletreeposter2006
 

PHIGClinical Skills Workshop

  • 1. Clinical Skills Workshop: Overdose Prevention and Response — Administering Naloxone to Save Lives POPULATION HEALTH INTEREST GROUP SEPTEMBER 8, 2016
  • 2. Conflict of Interest Disclaimer  No financial disclosures.  Adapt Pharma provided one trainer of its nasal spray (no medicine) for demonstration.  Kaleo provided Evzio autoinjectable trainers (no medicine) for demonstration.
  • 3.
  • 5. National Overdose Deaths Number of Deaths from Prescription Drugs 0 5,000 10,000 15,000 20,000 25,000 30,000 Total Female Male Source: National Center for Health Statistics, CDC Wonder
  • 6. National Overdose Deaths Number of Deaths from Prescription Opioid Pain Relievers 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 Total Female Male Source: National Center for Health Statistics, CDC Wonder
  • 7. National Overdose Deaths Number of Deaths from Heroin 0 2,000 4,000 6,000 8,000 10,000 12,000 Total Female Male
  • 8. Whom are we talking about?
  • 10.
  • 11. It’s more than “use as directed” An adverse reaction can occur if:  Co-morbidities: lungs, liver, kidneys, etc.  Co-pharmacy: e.g. sedative  Genetic susceptibility  Drinking alcohol  User error  Period of abstinence  Switching opioids  Family member may help themselves
  • 12.
  • 13. When to write a script  If patient is prescribed an opioid medication.  If patient is using opioids of any kind.  After a period of abstinence (any kind, including incarceration or drug treatment).  If pt. has experienced an overdose or adverse reaction.  If pt. has witnessed an overdose or adverse reaction.  If pt. asks for it.  If pt. has a household member who might benefit from it.
  • 14.
  • 16.
  • 17. Enabling? No! Safe? Yes! • Been around since 1961 • Communities have been distributing since 1996 • No compensatory behavior since it causes withdrawal. • No potential for abuse. • People use it. • Leads to treatment for substance use disorder. • Decrease in deaths much greater than amount supplied, indicating decrease in risky behavior as result of the educational process that is part of providing rx.
  • 18. Si se puede!  150K laypersons trained.  26K OD reversed .  80% of reversals were performed by drug users  In North Carolina, their three-year-old program has had 4,000 reversals.  FDA working on making it OTC.  FDA changing labels on all opiates and benzos.
  • 20. To script or not to script  There may not be a standing order in your state.  Standing order may only be for certain pharmacies.  Pharmacist may not be aware of standing order.  Patient may not know to ask for it.  Patient may not remember to ask for it.  Easier to pick up all rx at once.  Less worry about payment and billing issues.  There is no downside to writing a script.
  • 21. Your new best friend: www.prescribetoprevent.org One-stop shopping for patients, advocates, prescribers, pharmacists: videos, online CME, research, legal info, billing, Rx pads, and things you never thought you might need.  Where do we go from here?  Train your classmates: this is an easy brown-bag lunch session.  Show video(s)  Give demo  Tell people where to get it for themselves  Make this a national AMSA Project, educating medical students, college students, incarcerated populations, drug treatment programs, faith communities, etc.
  • 22. Thank you! Mary Beth Levin, MPH Associate Professor Department of Family Medicine Georgetown University School of Medicine levinmb@gmail.com Other resources: Harm Reduction Coalition: www.harmreduction.org North Carolina Harm Reduction Coalition: www.nchrc.org Chicago Recovery Alliance: www.anypoisitivechange.org

Editor's Notes

  1. National Overdose Deaths—Number of Deaths from Prescription Drugs. The figure above is a bar chart showing the total number of U.S. overdose deaths involving prescription drugs from 2001 to 2014. The chart is overlayed by a line graph showing the number of deaths by females and males. From 2001 to 2014 there was a 2.8-fold increase in the total number of deaths.
  2. National Overdose Deaths—Number of Deaths from Prescription Opioid Pain Relievers. The figure above is a bar chart showing the total number of U.S. overdose deaths involving opioid pain relievers from 2001 to 2014. The chart is overlayed by a line graph showing the number of deaths by females and males. From 2001 to 2014 there was a 3.4-fold increase in the total number of deaths.
  3. National Overdose Deaths—Number of Deaths from Heroin. The figure above is a bar chart showing the total number of U.S. overdose deaths involving heroin from 2001 to 2014. The chart is overlayed by a line graph showing the number of deaths by females and males. From 2001 to 2014 there was a 6-fold increase in the total number of deaths.